| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8453351 | Leukemia Research | 2018 | 5 Pages |
Abstract
Allo-HCT is an effective treatment for T-PLL. Patients must be evaluated for their candidacy for allo-HCT as soon as the diagnosis is confirmed. Efforts are needed to decrease NRM and relapse.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Bhagirathbhai R. Dholaria, Ernesto Ayala, Lubomir Sokol, Taiga Nishihori, Julio C. Chavez, Mohammad Hussaini, Ambuj Kumar, Mohamed A. Kharfan-Dabaja,